Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 26: FAST III - FFR vs vFFR to Guide Revascularisation
Author(s): Joost Daemen Added: 2 months ago
American College of Cardiology Congress 2026 - Dr Joost Daemen (Thoraxcenter, Erasmus University Medical Center, Rotterdam, NL) joins us to discuss findings from the FAST III trial (NCT04931771; ECRI) a large-scale randomised study comparing fractional flow reserve (FFR) with 3D-quantitative coronary angiography-derived vessel FFR (vFFR) to guide coronary revascularisation.This randomised, open… View more

Intervention
LINC 25: 36-Month Update on Aspirex Endovascular Thrombectomy System
Author(s): Michael Lichtenberg Added: 1 year ago
LINC 2025 - 36-month outcomes of the Aspirex endovascular thrombectomy system for patients with acute iliofemoral deep vein thrombosis (DVT) show great efficacy with low rates of major adverse events, perioperative death, and complication.Dr Michael Lichtenberg (Vascular Centre Clinic Arnsberg, Arnsberg, DE) joins us to discuss the findings from the multi-centre, post-market, follow-up study in… View more

Vascular Disease and Surgery
Revascularisation in Patients with Cancer
Author(s): Miguel Nobre Menezes , Mamas A Mamas Added: 4 months ago

Intervention

Prevention & Chronic Conditions
OPTION-STEMI: Staged Revascularisation for STEMI with HF
Added: 2 months ago Source:  Cardiac Failure Review
The optimal timing for complete revascularisation in patients with ST-segment elevation myocardial infarction (STEMI) and multi-vessel disease who also present with heart failure is a key clinical question. A pre-specified subgroup analysis of the OPTION-STEMI trial suggests that a staged approach may be preferable to immediate complete revascularisation in this high-risk patient group… View more

Intervention

MI/ACS
EuroPCR 25: The DANAMI-3-PRIMULTI Trial
Author(s): Thomas Engstrøm Added: 1 year ago
EuroPCR 25 - 10-year outcomes from DANAMI-3-PRIMULTI show FFR-guided complete revascularisation in ST-elevation myocardial infarction (STEMI) reduces the risk of future events. We are joined by Dr Thomas Engstrøm (University of Copenhagen, Copenhagen, Denmark) to discuss 10-year outcomes from the multicenter, randomized DANAMI-3-PRIMULTI trial investigating FFR-guided complete… View more

Demographic

MI/ACS
Lukla Biasi
Research Area(s) / Expertise:

Peripheral Artery Disease - General

 Job title: Consultant Vascular & Endovascular Surgeon
Dr Lukla Biasi is an experienced vascular and endovascular surgeon with a dedicated commitment to the sub-specialties of lower limb revascularisation and carotid surgery. Lukla Biasi graduated with distinguished honours from the University of Bologna, Italy; following a research fellowship at St Georges’ Vascular Institute in London, he completed the specialist training at the University… View more
Job title: Vascular and Endovascular Surgeon
Lukla Biasi is an experienced vascular and endovascular surgeon with a dedicated commitment to the sub-specialty of lower limb revascularisation. He was appointed as a consultant vascular surgeon at St Thomas’ in 2016. He is an active member of the diabetic foot care team and he is running vascular and diabetic foot clinics at Tunbridge Wells Hospital. Prior to this, following a clinical… View more
Job title: Vascular and Endovascular Surgeon
Mr Saratzis is an Associate Professor of Vascular Surgery and Honorary Vascular and Endovascular Surgeon with an interest in clinical and translational research. His clinical focus is complex peripheral revascularisation. He is currently based at the NIHR Leicester Biomedical Research Centre (BRC) and Department of Cardiovascular Sciences (University of Leicester), supported by an NIHR Advanced… View more
Job title: Clinical Senior Lecturer and Consultant Vascular Surgeon
Prakash Saha is a clinical senior lecturer at Kings College and honorary consultant endovascular surgeon at Guy's and St Thomas' Hospital, London, UK where he is the clinical lead for venous and lymphoedema surgery.Following the completion of his Wellcome Trust-funded PhD in 2012, Dr Saha has remained active in research and been awarded research grants from the Royal College of Surgeons, Royal… View more
Left Main Disease: The Last Frontier for Medical Therapy in Stable CAD?
Author(s): Armin Arbab-Zadeh , Michelle Graham , Hector M Garcia-Garcia , et al Added: 9 months ago

Intervention

Prevention & Chronic Conditions